Want to see TAK full AI Analyst Report?
ETFs with Takeda Pharmaceutical Company (TAK) Exposure
The following ETFs maintain exposure to Takeda Pharmaceutical Company (TAK). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
21 ETFs Hold Takeda Pharmaceutical Company (TAK)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in TAK |
|---|---|---|---|---|---|---|
| PPH | VanEck Pharmaceutical ETF | $1.08B | 0.36% | 2.79% | $29.98M | 0.05% |
| PHW | Purpose Intl TacHgEq | $2.02M | 1.57% | 1.45% | $196.51K | <0.01% |
| GINX | SGI Enhanced Global Income ETF | $107.18M | 1.02% | 0.78% | $841.16K | <0.01% |
| FVD | First Trust Value Line Dividend Index Fund | $8.05B | 0.62% | 0.42% | $33.94M | 0.05% |
| FUD | 1st Tr AlphaUSDiv Un | $7.73M | 0.79% | 0.40% | $31.41K | <0.01% |
| JSTC | Adasina Social Justice All Cap Global ETF | $300.92M | 0.89% | 0.40% | $1.19M | <0.01% |
| IDVO | Amplify International Enhanced Dividend Income ETF | $1.40B | 0.65% | 0.36% | $5.00M | <0.01% |
| APIE | ActivePassive International Equity ETF | $1.13B | 0.45% | 0.27% | $3.04M | <0.01% |
| AVPE | American Century ICAV - Avantis Pacific Equity Ucits Etf | $16.38M | 0.26% | 0.21% | $35.04K | <0.01% |
| AVNC | Avantis All International Core Equity ETF | $99.60M | 0.27% | 0.09% | $91.13K | <0.01% |
| AVSD | Avantis Responsible International Equity ETF | $376.48M | 0.23% | 0.07% | $244.02K | <0.01% |
| CADE | Avantis CIBC International Equity ETF Common Units Trust Units | $351.25M | ― | 0.06% | $208.41K | <0.01% |
| AVDE | Avantis International Equity ETF | $19.65B | 0.23% | 0.06% | $11.31M | 0.02% |
| BDYN | iShares Dynamic Equity Active ETF | $3.16B | 0.39% | 0.06% | $1.79M | <0.01% |
| AVGC | American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD | $880.70M | 0.23% | 0.01% | $123.50K | <0.01% |
| AVUS | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | 0.01% | $123.50K | <0.01% |
| VEU | Vanguard FTSE All-World ex-US Index Fund | $67.31B | 0.04% | <0.01% | $2.24M | <0.01% |
| DFIC | Dimensional International Core Equity 2 ETF | $15.36B | 0.22% | <0.01% | $141.05K | <0.01% |
| DFAX | Dimensional World ex U.S. Core Equity 2 ETF | $12.19B | 0.28% | <0.01% | $105.33K | <0.01% |
| DDGC | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | <0.01% | $4,002 | <0.01% |
| FENI | Fidelity Enhanced International ETF | $11.69B | 0.28% | <0.01% | $3,081.54 | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in TAK |
|---|---|---|---|---|---|---|
| PPH | 2.79% | VanEck Pharmaceutical ETF | $1.08B | 0.36% | $29.98M | 0.05% |
| PHW | 1.45% | Purpose Intl TacHgEq | $2.02M | 1.57% | $196.51K | <0.01% |
| GINX | 0.78% | SGI Enhanced Global Income ETF | $107.18M | 1.02% | $841.16K | <0.01% |
| FVD | 0.42% | First Trust Value Line Dividend Index Fund | $8.05B | 0.62% | $33.94M | 0.05% |
| FUD | 0.40% | 1st Tr AlphaUSDiv Un | $7.73M | 0.79% | $31.41K | <0.01% |
| JSTC | 0.40% | Adasina Social Justice All Cap Global ETF | $300.92M | 0.89% | $1.19M | <0.01% |
| IDVO | 0.36% | Amplify International Enhanced Dividend Income ETF | $1.40B | 0.65% | $5.00M | <0.01% |
| APIE | 0.27% | ActivePassive International Equity ETF | $1.13B | 0.45% | $3.04M | <0.01% |
| AVPE | 0.21% | American Century ICAV - Avantis Pacific Equity Ucits Etf | $16.38M | 0.26% | $35.04K | <0.01% |
| AVNC | 0.09% | Avantis All International Core Equity ETF | $99.60M | 0.27% | $91.13K | <0.01% |
| AVSD | 0.07% | Avantis Responsible International Equity ETF | $376.48M | 0.23% | $244.02K | <0.01% |
| CADE | 0.06% | Avantis CIBC International Equity ETF Common Units Trust Units | $351.25M | ― | $208.41K | <0.01% |
| AVDE | 0.06% | Avantis International Equity ETF | $19.65B | 0.23% | $11.31M | 0.02% |
| BDYN | 0.06% | iShares Dynamic Equity Active ETF | $3.16B | 0.39% | $1.79M | <0.01% |
| AVGC | 0.01% | American Century ICAV - Avantis Global Equity UCITS ETF Accum- USD | $880.70M | 0.23% | $123.50K | <0.01% |
| AVUS | 0.01% | Avantis Global Equity Ucits ETF | $116.86M | 0.21% | $123.50K | <0.01% |
| VEU | <0.01% | Vanguard FTSE All-World ex-US Index Fund | $67.31B | 0.04% | $2.24M | <0.01% |
| DFIC | <0.01% | Dimensional International Core Equity 2 ETF | $15.36B | 0.22% | $141.05K | <0.01% |
| DFAX | <0.01% | Dimensional World ex U.S. Core Equity 2 ETF | $12.19B | 0.28% | $105.33K | <0.01% |
| DDGC | <0.01% | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | $4,002 | <0.01% |
| FENI | <0.01% | Fidelity Enhanced International ETF | $11.69B | 0.28% | $3,081.54 | <0.01% |
Popular ETF Comparisons
TAK ETF Exposure FAQ
What ETFs hold Takeda Pharmaceutical Company stock?
Takeda Pharmaceutical Company (TAK) is currently held by 21 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to TAK include First Trust (FVD), VanEck (PPH) and Amplify (IDVO).
Which ETF has the largest exposure to TAK?
The ETF with the largest exposure to TAK is First Trust (FVD), with approximately $33.94M in market value exposure.
How much TAK stock is held by ETFs?
ETFs currently hold approximately $74.35M worth of Takeda Pharmaceutical Company (TAK) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.